News
SAN CARLOS, Calif. — BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback